In a Phase 2 clinical trial published in the New England Journal of Medicine (2023), the compound demonstrated unprecedented metabolic effects: Average weight reduction: 24.2% of total body weight at 48 weeks (24mg dose)
Targets Hyperpigmentation: Aims to reduce dark spots, blemishes, and uneven skin tone
Sargin P, Roethle MF, Jia S, Pant T, Ciecko AE, Atkinson SN, Salzman NH, Teng RJ, Chen YG, Cabrera SM, Hessner MJ (2022) Lactiplantibacillus plantarum 299v supplementation modulates -cell ER stress and antioxidative defense pathways and prevents type 1 diabetes in gluten-free BioBreeding rats
According to guidelines, pharmaceutical companies and their logistics partners must validate their cold chain processes, demonstrating that their packaging and transportation methods can maintain the required temperature conditions